Assignment of Assignor's Interest

Recorded: 2020-10-29 Pages: 3

Assignor

WEIDANZ, JON

Executed: 2019-05-20

Assignee

ABEXXA BIOLOGICS, INC.

NANOFAB BUILDING, BOX 19072, ARLINGTON, TEXAS, 76019

Covered Property (1)

Combination Cancer Therapy with Anti-Cancer Agents and Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen

Application: 16/975,364 →

Publication: US 2020/0399377